Journey Medical Corp
Company Stats
- Market Cap
- $193.1M
- as of Sep 30, 2026
- Enterprise Value
- $195.2M
- Shares Outstanding
- 28.2M
- Free Float
- 27.0%
Income Statement
- Revenue
- $61.9M
- Operating Income
- -$8.2M
- Net Income
- -$11.4M
- Revenue Growth, 3Y
- -5.7%
Balance Sheet
- Cash & Equivalents
- $24.1M
- Total Debt
- $26.2M
- Net Debt
- $2.2M
Returns & Capital
- SBC, 3Y Avg
- $5.0M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $61.9M | — | — |
| FY2024 | $56.1M | -$24.1M | -43.0% |
| FY2023 | $79.2M | $240,000 | 0.3% |
| FY2022 | $73.7M | -$33.5M | -45.5% |
| FY2021 | $63.1M | -$2.2M | -3.5% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 6, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges